Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
As of 2026-04-13, ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is trading at $12.95, posting a 2.78% gain in the current session. This analysis covers key market context, technical support and resistance levels, and potential near-term scenarios for the clinical-stage biotech stock, with a focus on key levels market participants are monitoring in the current environment. No recent earnings data is available for PMN as of this date, so recent price action is primarily being driven by techni
What events could move ProMIS (PMN) Stock next | Price at $12.95, Up 2.78% - Take Profit Levels
PMN - Stock Analysis
4999 Comments
1564 Likes
1
Shyrell
Consistent User
2 hours ago
Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
👍 59
Reply
2
Hubbie
Legendary User
5 hours ago
Provides clarity on technical and fundamental drivers.
👍 83
Reply
3
Sang
Legendary User
1 day ago
This feels like a silent agreement happened.
👍 83
Reply
4
Klaus
Senior Contributor
1 day ago
I understood enough to be unsure.
👍 260
Reply
5
Caterin
Experienced Member
2 days ago
This feels like a message for someone else.
👍 232
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.